دورية أكاديمية

Validation of a 22-gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413 and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High-Risk Prostate Cancer

التفاصيل البيبلوغرافية
العنوان: Validation of a 22-gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413 and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High-Risk Prostate Cancer
المؤلفون: Nguyen, P.L., Huang, H.C., Davicioni, E., Sandler, H.M., Shipley, W.U., Efstathiou, J.A., Simko, J., Pollack, A., Dicker, A.P., Roach, M., III, Rosenthal, S.A., Morginstin, M., Mendez, L., Hartford, A.C., Hall, W.A., Desai, A.B., Rabinovitch, R., Peters, C.A., Rodgers, J., Feng, F.Y.
المصدر: In International Journal of Radiation Oncology, Biology, Physics 1 November 2021 111(3) Supplement:S50-S50
قاعدة البيانات: ScienceDirect
الوصف
تدمد:03603016
DOI:10.1016/j.ijrobp.2021.07.133